4D Molecular Therapeutics develops genetic medicines for eye diseases and cystic fibrosis, based in Emeryville, California. It last closed at $10.79 on Nov 17, down 4.43% on the day. The average 12-month price target from 3 analysts is $26.00 (+141.0% from the last close), with a high of $33.00 and a low of $20.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Each firm's latest rating on FDMT in the past 90 days
Average 12-month target
$26.00
▲ 141.0% upside
Based on 3 analysts who set a price target on FDMT in the past 90 days. The average target is $26.00, with a high of $33.00 and a low of $20.00, compared with the last close of $10.79.
Low $20.00Avg $26.00High $33.00
Blue marker: last close $10.79
Highest target$33.00
Average target$26.00
Lowest target$20.00
Latest rating changes
Chardan CapitalMaintained
Oct 6Buy$25
B of A SecuritiesMaintained
Sep 29Buy$33
Cantor FitzgeraldUpgrade
Sep 14Buy$20
B. Riley SecuritiesInitiated
Jul 31Buy$37
HC Wainwright & Co.Reiterated
Jul 20Buy$36
Date
Firm
Action
Rating
Price target
Oct 6
Chardan Capital
Maintained
Buy
$25
Sep 29
B of A Securities
Maintained
Buy
$33
Sep 14
Cantor Fitzgerald
Upgrade
Buy
$20
Jul 31
B. Riley Securities
Initiated
Buy
$37
Jul 20
HC Wainwright & Co.
Reiterated
Buy
$36
Loading…
Technical Analysis
FDMT · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock is 11% below its 20 day and 20% below its 50 day average. It is 3% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 40). The nearest support is the swing low (Oct 26) at $10.62, and the nearest resistance the Pivot at $10.91.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 8.7%/day
Key levels
$16.9352 week high+56.9%
$12.9950 day average+20.4%
$12.78100 day average+18.4%
$11.9720 day average+10.9%
$11.96Swing high (Jul 21)+10.8%
$11.28Pivot R1+4.5%
$11.10200 day average+2.9%
$10.91Pivot+1.1%
$10.79Last close
$10.62Swing low (Oct 26)−1.6%
$10.42Pivot S1−3.4%
$6.9652 week low−35.5%
Indicators
RSI (14)
39.76
Weak, oversold below 30
Neutral
MACD
-0.33
Below its signal line
Bearish
Stochastic
25.3
Middle of its range
Neutral
ADX (14)
11.6
No clear trend
Williams %R
-91.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-143.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.7%
Change over 10 sessions
Bearish
ATR (14)
$0.94
Typical daily range, 8.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 18.2%/day
Key levels
$16.9352 week high+56.9%
$12.9950 day average+20.4%
$12.78100 day average+18.4%
$11.9720 day average+10.9%
$11.96Swing high (Jul 21)+10.8%
$11.28Pivot R1+4.5%
$11.10200 day average+2.9%
$10.91Pivot+1.1%
$10.79Last close
$10.62Swing low (Oct 26)−1.6%
$10.42Pivot S1−3.4%
$6.9652 week low−35.5%
Indicators
RSI (14)
45.76
Middle of its range
Neutral
MACD
0.35
Below its signal line
Bearish
Stochastic
22.0
Middle of its range
Neutral
ADX (14)
28.0
Trending up
Williams %R
-96.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-68.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−18.1%
Change over 10 sessions
Bearish
ATR (14)
$1.96
Typical daily range, 18.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for FDMT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how FDMT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow FDMT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How FDMT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FDMT is in one of them and how their past FDMT trades turned out.
4D Molecular Therapeutics is a biotechnology company that develops genetic medicines. Its product candidates use modified adeno-associated virus vectors, which are designed to carry therapeutic genes to target tissues. Its lead candidate is aimed at wet age-related macular degeneration and diabetic macular edema, two eye diseases, and is designed to be given by injection in a doctor's office. The company is also developing a treatment for lung disease in people with cystic fibrosis. It is based in Emeryville, California, and its intended customers are patients, eye and lung specialists, and healthcare payers.